UBD and hepatocellular carcinoma: These included the promoters of UBD (FAT10), a ubiquitin‐like modifier, and the calponin TAGLN2, both implicated in the progression of HCC, and BAIAP2L2 coding for insulin receptor tyrosine kinase substrate, associated with actin remodelling and promoting HCC proliferation [57, 58, 59].